CIK: 0001082621 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 7, 2021
Total Value ($000): $1,789,985 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RPRX | ROYALTY PHARMA PLC | 10,714,284 | $467,357 | 26.1% | $49.50 | -4.2% | SHS CLASS A | G7709Q104 |
| ICE | INTERCONTINENTAL EXCHANGE IN | 2,062,444 | $230,334 | 12.9% | $106.46 | 0.0% | COM | 45866F104 |
| ADBE | ADOBE SYSTEMS INCORPORATED | 326,100 | $155,018 | 8.7% | $467.43 | 0.0% | COM | 00724F101 |
| ABCL | ABCELLERA BIOLOGICS INC | 4,105,095 | $139,409 | 7.8% | $45.73 | -12.9% | COM | 00288U106 |
| META | FACEBOOK INC | 409,695 | $120,667 | 6.7% | $245.43 | +8.9% | CL A | 30303M102 |
| PANW | PALO ALTO NETWORKS INC | 340,900 | $109,790 | 6.1% | $49.24 | +20.7% | COM | 697435105 |
| LNWO | SCIENTIFIC GAMES CORP | 2,678,571 | $103,179 | 5.8% | $21.43 | +109.2% | COM | 80874P109 |
| MSFT | MICROSOFT CORP | 261,792 | $61,723 | 3.4% | $206.04 | +8.2% | COM | 594918104 |
| CRM | SALESFORCE COM INC | 164,622 | $34,878 | 1.9% | $240.26 | -8.5% | COM | 79466L302 |
| QQQ | INVESCO QQQ TR | 107,944 | $34,448 | 1.9% | $220.86 | — | UNIT SER 1 | 46090E103 |
| PCT | PURECYCLE TECHNOLOGIES INC | 1,276,267 | $32,545 | 1.8% | $22.89 | 0.0% | COM | 74623V103 |
| RVMD | REVOLUTION MEDICINES INC | 670,382 | $30,757 | 1.7% | $27.68 | +62.0% | COM | 76155X100 |
| IVV | ISHARES TR | 65,516 | $26,064 | 1.5% | $181.43 | — | CORE S&P500 ETF | 464287200 |
| — | PRAXIS PRECISION MEDICINES I | 778,517 | $25,504 | 1.4% | $55.02 | — | COM | 74006W108 |
| PLRX | PLIANT THERAPEUTICS INC | 562,379 | $22,118 | 1.2% | $26.54 | +22.4% | COM | 729139105 |
| RLAY | RELAY THERAPEUTICS INC | 541,124 | $18,707 | 1.0% | $38.13 | +13.8% | COM | 75943R102 |
| U | UNITY SOFTWARE INC | 186,396 | $18,697 | 1.0% | $123.17 | 0.0% | COM | 91332U101 |
| TXG | 10X GENOMICS INC | 89,476 | $16,195 | 0.9% | $172.69 | 0.0% | CL A COM | 88025U109 |
| SANA | SANA BIOTECHNOLOGY INC | 468,749 | $15,689 | 0.9% | $32.56 | 0.0% | COM | 799566104 |
| — | KINNATE BIOPHARMA INC | 498,001 | $15,518 | 0.9% | $39.78 | — | COM | 49705R105 |
| GLD | SPDR GOLD TR | 96,662 | $15,462 | 0.9% | $126.45 | — | GOLD SHS | 78463V107 |
| — | GENERATION BIO CO | 512,349 | $14,581 | 0.8% | $21.21 | — | COM | 37148K100 |
| RBLX | ROBLOX CORP | 197,642 | $12,813 | 0.7% | $69.70 | 0.0% | CL A | 771049103 |
| NRIX | NURIX THERAPEUTICS INC | 314,762 | $9,786 | 0.5% | $25.20 | +50.1% | COM | 67080M103 |
| VEA | VANGUARD TAX-MANAGED INTL FD | 175,937 | $8,640 | 0.5% | $35.96 | — | FTSE DEV MKT ETF | 921943858 |
| PDD | PINDUODUO INC | 42,490 | $5,689 | 0.3% | $133.89 | — | SPONSORED ADS | 722304102 |
| IJR | ISHARES TR | 50,304 | $5,459 | 0.3% | $70.20 | — | CORE S&P SCP ETF | 464287804 |
| — | NUCANA PLC | 992,405 | $4,952 | 0.3% | $5.93 | — | SPONSORED ADR | 67022C106 |
| FULC | FULCRUM THERAPEUTICS INC | 410,714 | $4,838 | 0.3% | $11.06 | +11.7% | COM | 359616109 |
| IJH | ISHARES TR | 16,129 | $4,198 | 0.2% | $125.72 | — | CORE S&P MCP ETF | 464287507 |
| VWO | VANGUARD INTL EQUITY INDEX F | 80,501 | $4,190 | 0.2% | $46.05 | — | FTSE EMR MKT ETF | 922042858 |
| — | FS DEVELOPMENT CORP II | 400,000 | $3,984 | 0.2% | $9.96 | — | COM CL A | 30318F100 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $3,938 | 0.2% | $12.01 | — | COM | 55910K108 |
| — | DECIBEL THERAPEUTICS INC | 328,798 | $3,735 | 0.2% | $11.36 | — | COM | 24343R106 |
| — | GEMINI THERAPEUTICS INC | 250,000 | $3,388 | 0.2% | $13.55 | — | COM | 36870G105 |
| — | SERES THERAPEUTICS INC | 131,847 | $2,715 | 0.2% | $24.50 | — | COM | 81750R102 |
| DYN | DYNE THERAPEUTICS INC | 107,252 | $1,666 | 0.1% | $21.96 | -11.9% | COM | 26818M108 |
| — | DADA NEXUS LTD | 49,887 | $1,354 | 0.1% | $27.14 | — | ADS | 23344D108 |